0.3349USD+1.52%Mkt Cap: 9.49M USDP/E: —Last update: 2026-06-01
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various t…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap9.49M USD
Enterprise Value19.13M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-4.23M USD
Revenue/Share—
Last Price0.3349 USD
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B25.58
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.26201% of range9.180
52W High9.180 USD
52W Low0.2620 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-37.66%
ROA-36.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.48M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-5.31%
Net Debt367.59K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio9.37
Quick Ratio1.43
Book Value/Sh0.0130 USD
Cash/Share0.0040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.28.34M
Float8.91M
Insiders67.81%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Float0.67%
Short % Out.0.48%
Shares Short137.29K
Short (prev mo.)115.46K
Technical
SMA 500.4137 (-19.1%)
SMA 2000.9849 (-66.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)95.32K
Avg Vol (10d)62.48K
Technical Indicators
RSI (14)40.9
MACD-0.0209
MACD Signal-0.0266
MACD Hist.+0.0058
BB Upper0.3737 USD
BB Middle0.3309 USD
BB Lower0.2881 USD
BB Width25.87%
ATR (14)0.0317 USD
Vol Ratio (20d)0.40x